Figure 1C shows mRNA expression levels of ARHGAP30 in subgroups of patients with LUAD, stratified based on sample type, individual cancer stage, ethnicity, sex, age, smoking habit, nodal metastasis status, and TP53 mutation status (UALCAN [14]). Here, ARHGAP30 is linked to cancer.